Endocrine Function Diagnostics Market

Endocrine Function Diagnostics Market by Test Types (Insulin Test, Thyroid Test, Sexual Dysfunction Test, and Others) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1912
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 195
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global endocrine function diagnostics market size is projected to register a substantial CAGR during the forecast period attributed to increase in number of endocrine disorders and advancement of technology for their diagnosis.

Endocrine Function Diagnostics Market Key Takeaways

The hormones in the human body are produced by a group of glands known as the endocrine system. These endocrine glands control various body functions such as growth, reproduction, metabolism, sexual development, and others. The occurrence of minute changes in these glands results in endocrine disorders. Endocrine function diagnostics help in the diagnosis of hormonal disorders including diabetes and thyroid diseases. Major glands that are included in endocrine glands are the ovary, testes, thyroid, pineal gland, parathyroid, adrenal glands, hypothalamus, Islet cells in the pancreas, and pituitary glands. Some key endocrine disorders are diabetes, polycystic ovary syndrome (PCOS) adrenal deficiency, hyperthyroidism, cushing’s syndrome, and hypothyroidism.

The COVID-19 pandemic outbreak is anticipated to have a significant impact on the market as some scientific theory suggests that people suffering from thyroid are more likely to be infected by COVID-19. This presents a vital aspect for the market expansion. According to a study named as Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study”, it is observed that the levels of TSH and TT3 are inversely proportional to COVID-19, which means the less the TSH and TT3 levels are the severe the COVID-19 is and vice versa.

Market Trends, Drivers, Restraints, and Opportunities

  • Increase in incidence of diabetes and other diseases such as PCOS and hyperthyroidism is expected to propel the market growth. As per a report, approximately 5% of women at their reproductive age are expected to be affected by PCOS.
  • Advancement of technology for diagnosis in order to achieve system automation is anticipated to boost the growth of the market.
  • Improvement in reimbursement policies across the globe and existing favorable regulatory frameworks are key factors driving the market growth.
  • Consumption of alcohol is a major reason for several endocrine disorders. Rising cases for excessive consumption of alcohol among adults is a major factor that is anticipated to help the market growth.
  • High cost of the diagnosis and treatment of the disorder is likely to hamper the growth of the market.

Scope of the Report

The report on the global endocrine function diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Endocrine Function Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Test Types (Insulin Test, Thyroid Test, Sexual Dysfunction Test, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

Bio-Rad Laboratories; Siemens Healthcare; Abbott Laboratories; Roche Diagnostics; Dako; Beckman Coulter Inc.; Sysmex; Thermo Fisher; and Eiken

Market Segment Insights

Thyroid test segment is expected to expand at a lucrative growth

On the basis of test types, the global endocrine function testing market is categorized as insulin test, thyroid test, sexual dysfunction test, and others. The insulin test segment is projected to hold a large share of the market in the coming years owing to the increase in number of diabetes cases globally. A report by International Diabetes Federation states that the number of diabetes cases is expected to grow from 382 million in 2013 to 592 million in 2035 globally. However, the thyroid segment is anticipated to grow at a lucrative growth during the forecast period mainly owing to technological advancement that helps in disease screening.

Endocrine Function Diagnostics Market By Test Types

North America is anticipated to constitute a key market share

In terms of region, the global endocrine function testing market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to high awareness among people regarding the disorders. Moreover, the high expenditures for healthcare, launch of new products, and taking various initiatives including mandatory congenital hypothyroidism for newborns are key factors driving the regional market growth. Another reason for boosting the market is growing number of thyroid cases, which are mainly caused due to less physical activities. According to a report by Health and Human Services (HHS), only 5% of people in the US are involved in physical activities for 30 minutes. The report further states that it proves that approximately 80% of the adults in the country do not fulfill the protocols for strengthening of muscles, which normally results to obesity and hormonal imbalance.

Endocrine Function Diagnostics Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Endocrine Function Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Endocrine Function Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Endocrine Function Diagnostics Market - Supply Chain
  4.5. Global Endocrine Function Diagnostics Market Forecast
     4.5.1. Endocrine Function Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Endocrine Function Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Endocrine Function Diagnostics Market Absolute $ Opportunity
5. Global Endocrine Function Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Endocrine Function Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
6. North America Endocrine Function Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Endocrine Function Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
7. Latin America Endocrine Function Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Endocrine Function Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
8. Europe Endocrine Function Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Endocrine Function Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific Endocrine Function Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Endocrine Function Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa Endocrine Function Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Endocrine Function Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Endocrine Function Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Endocrine Function Diagnostics Market: Market Share Analysis
  11.2. Endocrine Function Diagnostics Distributors and Customers
  11.3. Endocrine Function Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Bio-Rad Laboratories Siemens Healthcare Abbott Laboratories Roche Diagnostics Dako Beckman Coulter Inc.  
Segments Covered in the Report
The global endocrine function diagnostics market has been segmented on the basis of

Test Types
  • Insulin Test
  • Thyroid Test
  • Sexual Dysfunction Test
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Bio-Rad Laboratories
  • Siemens Healthcare
  • Abbott Laboratories
  • Roche Diagnostics
  • Dako
  • Beckman Coulter Inc.
  • Sysmex
  • Thermo Fisher
  • Eiken

Key players competing in the global endocrine function diagnostics market are Bio-Rad Laboratories; Siemens Healthcare; Abbott Laboratories; Roche Diagnostics; Dako; Beckman Coulter Inc.; Sysmex; Thermo Fisher; and Eiken. Many of these players have adopted business strategies such as launching new products, introducing new technology, merger, partnership, and production capacity expansion to increase their market position and expand their consumer base globally.

Endocrine Function Diagnostics Market By Key Players

Buy Report